Anaplastic lymphoma kinase (ALK) is one of the insulin receptor superfamily of RTKs, and it was firstly identified as a result of cloning the nuclear protein nucleophosmin (NPM)–ALK fusion gene in anaplastic large-cell lymphomas [14]. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.